Related references
Note: Only part of the references are listed.Proton pump inhibitors and severe hypomagnesaemia
Tim Cundy et al.
CURRENT OPINION IN GASTROENTEROLOGY (2011)
Gastric Acid-Reducing Medications and Clopidogrel: What Are the Latest FDA Recommendations?
Amer A. Alkhatib et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Severe Hypomagnesemia During Long-term Treatment With a Proton Pump Inhibitor
Giuseppe Regolisti et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
A Case Series of Proton Pump Inhibitor-Induced Hypomagnesemia
Ewout J. Hoorn et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors A Cohort Study
Wayne A. Ray et al.
ANNALS OF INTERNAL MEDICINE (2010)
Conflicting Evidence Surrounding the Clopidogrel and Proton Pump Inhibitor Drug Interaction Reply
Karen M. Stockl et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Risk of Rehospitalization for Patients Using Clopidogrel With a Proton Pump Inhibitor
Karen M. Stockl et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Iatrogenic Gastric Acid Suppression and the Risk of Nosocomial Clostridium difficile Infection
Michael D. Howell et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Hip Fracture Risk in Patients With a Diagnosis of Pernicious Anemia
Nathan A. Merriman et al.
GASTROENTEROLOGY (2010)
Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density Loss
Laura E. Targownik et al.
GASTROENTEROLOGY (2010)
Proton Pump Inhibitors and Histamine-2 Receptor Antagonists Are Associated With Hip Fractures Among At-Risk Patients
Douglas A. Corley et al.
GASTROENTEROLOGY (2010)
Risk of fractures in patients with pernicious anemia
Jean B. Goerss et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Use of Proton-Pump Inhibitors in Early Pregnancy and the Risk of Birth Defects.
Bjorn Pasternak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study
Sascha Dublin et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series
J. D. Mackay et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Rebound acid hypersecretion from a physiological, pathophysiological and clinical viewpoint
Helge L. Waldum et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2010)
Lack of Acid and Symptom Rebound After Withdrawal of 4 to 8 Weeks of Dexlansoprazole MR or Lansoprazole Therapy
David C. Metz et al.
GASTROENTEROLOGY (2010)
Proton Pump Inhibitor Use and Enteric Infections
M. Sandra Dial
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Effect of Proton Pump Inhibitors on Vitamins and Iron
Kenneth E. L. McColl
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Guidelines for Prevention of NSAID-Related Ulcer Complications
Frank L. Lanza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Long-term Safety Concerns with Proton Pump Inhibitors
Tauseef Ali et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Hypomagnesemia Induced by Several Proton-Pump Inhibitors
Maarten A. C. Broeren et al.
ANNALS OF INTERNAL MEDICINE (2009)
Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome
Jeremy A. Rassen et al.
CIRCULATION (2009)
First evidence of a possible association between gastric acid suppression during pregnancy and childhood asthma: a population-based register study
E. Dehlink et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Proton-Pump Inhibitor Therapy Induces Acid-Related Symptoms in Healthy Volunteers After Withdrawal of Therapy
Christina Reimer et al.
GASTROENTEROLOGY (2009)
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials
Michelle L. O'Donoghue et al.
LANCET (2009)
Cytochrome P-450 Polymorphisms and Response to Clopidogrel.
Jessica L. Mega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors
B. I. Hirschowitz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Long-term use of proton pump inhibitors and vitamin B12 status in elderly individuals
W. P. J. Den Elzen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Esomeprazole induces upper gastrointestinal tract transmucosal permeability increase
J. M. Mullin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Proton pump inhibitors and the risk of colorectal cancer
Eva M. van Soest et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Chronic use of proton-pump inhibitors associated with giardiasis: A rare cause of hypomagnesemic hypoparathyroidism?
A. Francois et al.
ANNALES D ENDOCRINOLOGIE (2008)
Proton-pump inhibitor use and the risk for community-acquired pneumonia
Monika Sarkar et al.
ANNALS OF INTERNAL MEDICINE (2008)
Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Elaine W. Yu et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Use of proton pump inhibitors and risk of osteoporosisrelated fractures
Laura E. Targownik et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2008)
Severe hypomagnesaemia in long-term users of proton-pump inhibitors
T. Cundy et al.
CLINICAL ENDOCRINOLOGY (2008)
Recent developments in intestinal magnesium absorption
Gary A. Quamme
CURRENT OPINION IN GASTROENTEROLOGY (2008)
Occurrence of community-acquired respiratory tract infection in patients receiving esomeprazole
Lennart Estborn et al.
DRUG SAFETY (2008)
Proton pump inhibitors: an update of their clinical use and pharmacokinetics
Shaojun Shi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
A case-control study of community-associated Clostridium difficile infection
M. H. Wilcox et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Do acid-lowering agents affect vitamin B12 status in older adults?
T. S. Dhamiarajan et al.
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2008)
Proton pump inhibitor use and risk of hip fractures in patients without major risk factors
James A. Kaye et al.
PHARMACOTHERAPY (2008)
Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases
Y. Doorduyn et al.
EPIDEMIOLOGY AND INFECTION (2008)
Lesson of the week - Omeprazole and refractory hypomagnesaemia
N. Shabajee et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion
David C. Metz et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Use of acid-suppressing drugs and the risk of bacterial gastroenteritis
Luis Alberto Garcia Rodriguez et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Gastroesophageal reflux symptoms during and after pregnancy: A longitudinal study
Enrique Rey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Long-term use of proton pump inhibitors does not affect the frequency, growth, or histologic characteristics of colon adenomas
M. Singh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Chronic proton pump inhibitor therapy and the risk of colorectal cancer
Yu-Xiao Yang et al.
GASTROENTEROLOGY (2007)
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis
Carol Hutchinson et al.
GUT (2007)
American college of gastroenterology guideline on the management of Helicobacter pylori infection
William D. Chey et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Current concepts in the management of Helicobacter pylori infection:: the maastricht III consensus report
P. Malfertheiner et al.
GUT (2007)
Use of proton pump inhibitors and the risk of community-acquired pneumonia - A population-based case-control study
Sinem Ezgi Gulmez et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Systematic review of the risk of enteric infection in patients taking acid suppression
Jennifer Leonard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Proton pump inhibitor use and risk of colorectal cancer: A population-based, case-control study
Douglas J. Robertson et al.
GASTROENTEROLOGY (2007)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Proton pump inhibitors and hospitalization for Clostridium difficile-ssociated disease:: A population-based study
Donna O. Lowe et al.
CLINICAL INFECTIOUS DISEASES (2006)
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy
M. Jalving et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Proton-pump inhibitors and hypomagnesemic hypoparathyroidism
Martin Epstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Proton pump inhibitors and gastric neoplasia
E. J. Kuipers
GUT (2006)
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture
P. Vestergaard et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands:: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections
Y Doorduyn et al.
EPIDEMIOLOGY AND INFECTION (2006)
Functional characterization of homo- and heteromeric channel kinases TRPM6 and TRPM7
M Li et al.
JOURNAL OF GENERAL PHYSIOLOGY (2006)
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children
RB Canani et al.
PEDIATRICS (2006)
Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial
L Lundell et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Pharmacokinetic drug interaction profiles of proton pump inhibitors
Henning Blume et al.
DRUG SAFETY (2006)
Gastric carcinoids - A temporal increase with proton pump introduction
N Hodgson et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2005)
Antiulcer drugs and gastric cancer
HL Waldum et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Effects of proton pump inhibitors on calcium carbonate absorption in women: A randomized crossover trial
MB O'Connell et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Gastric juice: A barrier against infectious diseases
TC Martinsen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)
The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study
O Diav-Citrin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Updated guidelines for the diagnosis and treatment of Gastroesophageal reflux disease
KR DeVault et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
A case-control study on adverse effects:: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults
RJ Valuck et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia
VR Sharma et al.
SOUTHERN MEDICAL JOURNAL (2004)
Frequent CpG island methylation in sporadic and syndromic gastric fundic gland polyps
SC Abraham et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2004)
Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs
RJF Laheij et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Meta-analysis:: proton pump inhibitors vs. H2-receptor antagonists -: their efficacy with antibiotics in Helicobacter pylori eradication
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Gastric acid-suppressive therapy and community-acquired respiratory infections
RJF Laheij et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Dysplasia in fundic gland polyps is associated with nuclear β-catenin expression and relatively high cell turnover rates
M Jalving et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2003)
Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea:: a systematic review
C Thomas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
A summary of Food and Drug Administration-reported adverse events and drug interactions occurring during therapy with omeprazole, lansoprazole and pantoprazole
J Labenz et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
The pharmacovigilance of pantoprazole - The results of postmarketing surveillance on 11 541 patients in England
LV Wilton et al.
DRUG SAFETY (2003)
Characteristics of diarrhoea in 10,008 users of lansoprazole in daily practice: which co-factors contribute?
AAMC Claessens et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Sporadic fundic gland polyps with epithelial dysplasia - Evidence for preferential targeting for mutations in the adenomatous polyposis coli gene
SC Abraham et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Altered cellular distribution of tuberin and glucocorticoid receptor in sporadic fundic gland polyps
JJ Wei et al.
MODERN PATHOLOGY (2002)
Sporadic fundic gland polyposis: A clinical, histological, and molecular analysis
M Torbenson et al.
MODERN PATHOLOGY (2002)
Use of proton pump inhibitors during pregnancy and rates of major malformations - A meta-analysis
S Nikfar et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity
K Zedtwitz-Liebenstein et al.
CRITICAL CARE MEDICINE (2002)
The burden of selected digestive diseases in the United States
RS Sandler et al.
GASTROENTEROLOGY (2002)
Spontaneous resolution of multiple fundic gland polyps after cessation of treatment with lansoprazole and Nissen fundoplication: a case report
GB Kazantsev et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Fundic gland polyps are not induced by proton pump inhibitor therapy
M Vieth et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2001)
Helicobacter pylori infection and the development of gastric cancer.
N Uemura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Proton pump inhibitors versus H2-antagonists:: a meta-anaiysis of their efficacy in treating bleeding peptic ulcer
JP Gisbert et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Alteration in digestion and absorption of nutrients during profound acid suppression
P Evenepoel
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2001)
Use of omeprazole during pregnancy -: no hazard demonstrated in 955 infants exposed during pregnancy
BAJ Källén
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
Non-Helicobacter pylori bacterial flora during acid-suppressive therapy:: differential findings in gastric juice and gastric mucosa
S Sanduleanu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Sporadic fundic gland polyps -: Common gastric polyps arising through activating mutations in the β-catenin gene
SC Abraham et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Gastric polyps: an update of their pathology and biological significance
G Oberhuber et al.
VIRCHOWS ARCHIV (2000)
The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies
RM Martin et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Fundic gland polyps in familial adenomatous polyposis - Neoplasms with frequent somatic adenomatous polyposis coli gene alterations
SC Abraham et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment
A Cats et al.
HUMAN PATHOLOGY (2000)
A new mechanism for anti-inflammatory actions of proton pump inhibitors - inhibitory effects on neutrophil-endothelial cell interactions
N Yoshida et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2000)
Long-term omeprazole treatment in resistant gastroesophageal reflux disease:: Efficacy, safety, and influence on gastric mucosa
EC Klinkenberg-Knol et al.
GASTROENTEROLOGY (2000)
A H+-gated urea channel:: The link between Helicobacter pylori urease and gastric colonization
DL Weeks et al.
SCIENCE (2000)
Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids
J Theisen et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2000)
Vitamin B-12 levels during prolonged treatment with proton pump inhibitors
CW Howden
JOURNAL OF CLINICAL GASTROENTEROLOGY (2000)
Share Paper
